Year

Vaccine Licensure

Legislation and/or Policy Statements

IOM Reports on Vaccine Safety

2002

 

 

Immunization Safety Review: Multiple Immunizations and Immune Dysfunction

Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders

Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer

2003

Live attenuated intranasal influenza vaccine approved for use in the United States in healthy individuals aged 5-49 years old (FluMist)

ACIP recommends that children 6 to 23 months of age be vaccinated annually against influenza beginning in the 2004-2005 influenza season

Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders

Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer

Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy

2004

 

 

Immunization Safety Review: Influenza Vaccines and Neurological Complications



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement